Aeluma, Inc.
For the period ended Jun 30, 2025. Filed Sep 9, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Sep 9, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
On May 14, 2025, our CEO, Mr. Jonathan Klamkin, adopted a plan intended as a “Rule 10b5-1 trading arrangement.”150,000 shares were sold under the plan on August 14, 2025. Mr. Klamkin terminated the plan on August 18, 2025. The plan was determined to be a “non-10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K of the Exchange Act. The plan was for the sale of up to 400,000 shares of the Company’s common stock, to occur between August 14, 2025 and December 13, 2025, in accordance with the prices and formulas set forth in the plan but given the plan was terminated, no further sales were or will be made pursuant hereto.
On June 23, 2025, one ofour directors, Mr. Steven DenBaars adopted a “Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K of the Exchange Act. His plan is for the sale of up to 130,000 shares of the Company’s common stock, to occur between October 6, 2025 and May 6, 2026, in accordance with the prices and formulas set forth in the plan.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.